You have 9 free searches left this month | to do more

rivaroxaban

Rivaroxaban is a drug used to treat Atrial Fibrillation, Venous Thromboembolism, Stroke, and other conditions. Rivaroxaban is being actively studied in 55 studies and prior, has been studied in 57.

Top SponsorsTop SitesTop Investigators
Janssen Research & Development, LLCLondon Health Sciences CentreJessica Franklin
PfizerHamilton General HospitalJeffrey Kline
Brigham and Women's HospitalBrigham and Women's HospitalUlf Landmesser
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
Not yet recruiting
  • Healthy
  • Rivaroxaban
  • Activated charcoal
  • Saint-etienne, France
    CHU de SAINT-ETIENNE
2021-11-16
Nov 16, 2021
L
Completed
  • Atherosclerosis
  • Torrance, California
    Los Angeles Biomedical Research Institute
2021-07-21
Jul 21, 2021
A
Recruiting
  • Cancer
  • +3 more
  • Santo André, São Paulo, Brazil
    Science Valley Research Institute
2021-08-03
Aug 3, 2021
N
Recruiting
  • Acute Coronary Syndrome
  • Left Ventricular Thrombus
  • Karachi, Sindh, Pakistan
    National Institute of Cardiovascular Diseases
2021-07-10
Jul 10, 2021
A
Terminated
  • Venous Thromboembolism
  • Cancer
  • Rivaroxaban
  • low-molecular heparine
  • Aachen, Germany
    Uniklinik
2021-04-28
Apr 28, 2021
S
Recruiting
  • Atrial Fibrillation
  • +3 more
  • Rivaroxaban
  • Seoul, Korea, Republic of
    Samsung Medical Center
2020-10-19
Oct 19, 2020
P
Not yet recruiting
  • Peripheral Arterial Disease
  • (no location specified)
2021-03-08
Mar 8, 2021
G
Recruiting
  • Cerebral Infarction
  • TIA
  • Rivaroxaban
  • Shenyang, China
    General Hospital of ShenYang Military Region
2021-02-01
Feb 1, 2021
U
Completed
  • Drug Interaction Study
  • St Johns Wort Extract
  • Rivaroxaban
  • Bern, Switzerland
    Inselspital
2020-10-30
Oct 30, 2020
O
Recruiting
  • Atrial Fibrillation
  • Ottawa, Ontario, Canada
    The Ottawa Hospital - General Campus
2021-10-29
Oct 29, 2021
O
Completed
  • Venous Thromboembolism
  • Edmonton, Alberta, Canada
  • +3 more
2021-10-31
Oct 31, 2021
C
Recruiting
  • Ventricular Mural Thrombosis
  • Rivaroxaban
  • Beijing, China
    Fuwai Hospital, Chinese Academy of Medical Sciences & Pecking Un
2021-07-22
Jul 22, 2021
U
Recruiting
  • Coronary Artery Disease
  • Jacksonville, Florida
    University of Florida
2021-10-21
Oct 21, 2021
C
Not yet recruiting
  • Pulmonary Embolism
  • Rivaroxaban
  • (no location specified)
2020-08-25
Aug 25, 2020
G
Completed
  • Type 2 Diabetic Patients
  • Dresden, Sachsen, Germany
  • +4 more
2021-02-10
Feb 10, 2021
P
Completed
  • Healthy
  • Secaucus, New Jersey
    Frontage Clinical Services Inc.
2020-09-02
Sep 2, 2020
S
Recruiting
  • Cerebrovascular Stroke
  • +3 more
  • Rivaroxaban
  • Hangzhou, Zhejiang, China
    Second Affiliated Hospital, School of Medicine, Zhejiang Univers
2021-07-19
Jul 19, 2021
D
Completed
  • Cerebral Vein Thrombosis
  • Damascus, Damascus Governorate, Syrian Arab Republic
    Damascus University
2020-09-24
Sep 24, 2020
M
Recruiting
  • Atrial Fibrillation
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital
2021-08-31
Aug 31, 2021
L
Not yet recruiting
  • Rivaroxaban
  • +2 more
  • Rivaroxaban
  • (no location specified)
2020-03-12
Mar 12, 2020
O
Active, not recruiting
  • Atrial Fibrillation
  • Acute Coronary Syndrome
  • Ottawa, Ontario, Canada
    University of Ottawa Heart Institute
2020-06-01
Jun 1, 2020
U
Recruiting
  • Cerebral Venous Thrombosis
  • Rivaroxaban
  • Standard of care
  • Calgary, Alberta, Canada
  • +12 more
2021-09-27
Sep 27, 2021
U
Not yet recruiting
  • Antiphospholipid Syndrome
  • +4 more
  • (no location specified)
2020-07-15
Jul 15, 2020
D
Recruiting
  • Atrial Fibrillation
  • Rivaroxaban
  • Catheter ablation
  • Roma, Italy
    Azienda Ospedaliero-Universitaria Policlinico Umberto I - Dipart
2020-06-04
Jun 4, 2020
A
Recruiting
  • Covid19
  • +2 more
  • Cairo, Please Select, Egypt
    Teachers Hospital
2021-02-02
Feb 2, 2021